X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs AJANTA PHARMA - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN LTD AJANTA PHARMA LUPIN LTD/
AJANTA PHARMA
 
P/E (TTM) x 30.0 20.8 144.1% View Chart
P/BV x 2.9 4.8 59.5% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 LUPIN LTD   AJANTA PHARMA
EQUITY SHARE DATA
    LUPIN LTD
Mar-18
AJANTA PHARMA
Mar-18
LUPIN LTD/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,4651,818 80.6%   
Low Rs7271,106 65.7%   
Sales per share (Unadj.) Rs349.6239.5 146.0%  
Earnings per share (Unadj.) Rs5.652.8 10.5%  
Cash flow per share (Unadj.) Rs29.659.5 49.7%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs300.3230.0 130.6%  
Shares outstanding (eoy) m452.0888.77 509.3%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.16.1 51.4%   
Avg P/E ratio x197.227.7 712.1%  
P/CF ratio (eoy) x37.124.6 150.8%  
Price / Book Value ratio x3.66.4 57.4%  
Dividend payout %90.00-   
Avg Mkt Cap Rs m495,502129,782 381.8%   
No. of employees `00017.06.8 250.8%   
Total wages/salary Rs m28,6473,765 760.9%   
Avg. sales/employee Rs Th9,273.63,128.4 296.4%   
Avg. wages/employee Rs Th1,681.0554.0 303.4%   
Avg. net profit/employee Rs Th147.4689.7 21.4%   
INCOME DATA
Net Sales Rs m158,04221,258 743.5%  
Other income Rs m1,504242 622.3%   
Total revenues Rs m159,54521,499 742.1%   
Gross profit Rs m31,4756,584 478.1%  
Depreciation Rs m10,859596 1,822.2%   
Interest Rs m2,0444 49,841.5%   
Profit before tax Rs m20,0766,226 322.5%   
Minority Interest Rs m-710-   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,8851,539 187.4%   
Profit after tax Rs m2,5134,686 53.6%  
Gross profit margin %19.931.0 64.3%  
Effective tax rate %14.424.7 58.1%   
Net profit margin %1.622.0 7.2%  
BALANCE SHEET DATA
Current assets Rs m122,09512,236 997.8%   
Current liabilities Rs m50,9563,461 1,472.5%   
Net working cap to sales %45.041.3 109.0%  
Current ratio x2.43.5 67.8%  
Inventory Days Days8560 140.5%  
Debtors Days Days12084 141.9%  
Net fixed assets Rs m129,87611,140 1,165.9%   
Share capital Rs m904177 511.1%   
"Free" reserves Rs m134,86620,237 666.4%   
Net worth Rs m135,77120,414 665.1%   
Long term debt Rs m64,24510 636,089.1%   
Total assets Rs m263,05424,486 1,074.3%  
Interest coverage x10.81,519.4 0.7%   
Debt to equity ratio x0.50 95,638.8%  
Sales to assets ratio x0.60.9 69.2%   
Return on assets %1.719.2 9.0%  
Return on equity %1.923.0 8.1%  
Return on capital %3.730.5 12.2%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53,14111,667 455.5%   
Fx outflow Rs m19,3351,616 1,196.8%   
Net fx Rs m33,80710,052 336.3%   
CASH FLOW
From Operations Rs m17,5122,854 613.5%  
From Investments Rs m-14,073-2,604 540.4%  
From Financial Activity Rs m-14,921-2 746,045.0%  
Net Cashflow Rs m-11,482248 -4,627.9%  

Share Holding

Indian Promoters % 46.6 73.8 63.1%  
Foreign collaborators % 0.2 0.0 -  
Indian inst/Mut Fund % 11.3 1.6 729.0%  
FIIs % 31.9 7.6 419.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.0 59.4%  
Shareholders   98,259 20,968 468.6%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN LTD With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  DIVIS LABORATORIES  ALEMBIC LTD  

Compare LUPIN LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Macroeconomic Cues Guide the Markets This Week(Podcast)

Global markets remained in pressure this week. Pound fell sharply as risk of chaotic Brexit rose.

Related Views on News

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

Does it Make Sense to Invest in Offshore Funds?(Outside View)

Nov 6, 2018

Many investors prefer to invest in offshore funds because of the rupee depreciation and on-going downtrend in the markets, but it is to be invested only when there is no option available to invest in India.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Nov 16, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE LUPIN LTD WITH

MARKET STATS